We are always delighted when our readers and friends are willing to support the services we provide through Prostate Cancer International. However, we aren’t dumb! We are also very understanding of the fact that many of you would rather support prostate cancer research! So … here’s something you should know about.
An anonymous and generous donor has just agreed to give $1,000,000 (yes, that’s 1 million dollars) in matching funds to the Prostate Cancer Foundation (PCF) if PCF can raise $1 million from other donors between now and midnight on December 31, 2017.
In other words, if you have been thinking about making a donation to the Prostate Cancer Foundation to support their research initiatives, now is the time to do this. If you give just $5.00 to PCF yourself, it will actually be worth $10.00. If you give $50.00, it will be worth $100.00. If you give $500.00 it will be worth $1,000.00. And so on. Click here to see the PCF news about this generous matching gift.
Of course if you could scrape up another $5.00 to help support what we do at Prostate Cancer International and to keep you informed about the prostate cancer news and help individual patients get educated and think through their options for management of their individual diagnoses, we certainly would be delighted too!
:O)
Your sitemaster
Filed under: Uncategorized |
THE "NEW" PROSTATE CANCER INFOLINK 
My opinion as a comment is that donations to prostate research could really help with the continued process of the recent blood tests that would be more accurate and could take the place of PSA blood tests now being used. Case in point, the current methods of obtaining a biopsy can be invasive even though some medical professionals have stated the practice of (most common method) 12 needle/punch with echo transrectal guide is not necessarily a risk even though the biopsy needles must puncture the rectum to obtain the samples removed from the prostate to send to a pathology lab for examination. The echo transrectal devise may not aid the urologist doing the procedure that none of the needle/punches actually missed the target and also removal of the samples which even though the needles that are withdrawn are retracted in a safety tube to prevent any tissue contamination to be left behind during this procedure can happen. Moving forward the latest testing and development of the use of IsoPSA blood test was published in May of 2017 (medicalxpress.com) and, if validated and adopted clinically, could significantly reduce the rate of unnecessary biopsies almost 50 percent. This would be especially effective for men who are diagnosed with a Gleason score of 3 + 3 = 6 under the active wait/watch program, as any changes in the PSA readings during the AW/WP, could necessitate another needle/punch transrectal biopsy and also men who have been diagnosed with a more rapid, invasive prostate cancer. I personally know a retired co-worker who told me he has been biopsied several times in past years because of the false positive results of his yearly PSA results but the pathology lab returns the results as “Benign prostate tissue. No evidence of malignancy.”
I am a prostate cancer survivor and on June 6, 2017, I had a complete radical prostatectomy. I chose this treatment because of not wanting to go through anymore biopsies, which could be the situation if I chose to leave the prostate in my body. My point is that having another procedure such as the new research for diagnosing prostate cancer with the new tests of isoPSA gives men a possible better, less invasive, accurate way of treating prostate cancer. This of course will take funding and donations to proceed with approval for the new procedure of obtaining the results of PSA testing.